Singapore first to top WHO’s classification of medical regulator
Achieving ML 4 brings Singapore closer to becoming a WHO listed authority, a new scheme that will be operational later this year and will list the world’s regulators of reference
Achieving ML 4 brings Singapore closer to becoming a WHO listed authority, a new scheme that will be operational later this year and will list the world’s regulators of reference
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
Guy Villax was also involved with the EFCG and Rx-360 associations and contributed to legislation being passed on both sides of the Atlantic to fight fake medicines and to level the playing field for GMP manufacturing.
Alchemee's flagship brand Proactiv@ is an iconic product synonymous with acne care
Haleon will have a portfolio of category-leading brands including Sensodyne, Voltaren, Panadol and Centrum
The 15-year agreement will leverage dedicated commercial fill-finish manufacturing capacity in the US for mRNA vaccines and therapies
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
The sale is expected to close in the first quarter of 2022
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
Subscribe To Our Newsletter & Stay Updated